Tectonic Therapeutic | AVRO - Należności Handlowe





Należności Handlowe Zmiana Data
Akebia Therapeutics USD 47.03M 19.19M 2025-12
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Celltrion KRW 2.05T 542.39B 2025-12
Cspc Pharmaceutical CNY 8.79B 64.64M 2025-12
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 1.23M 1.18M 2026-03
Divis Laboratories Ltd INR 29.99B 3.71B 2026-03
Gilead Sciences USD 4.74B 172M 2026-03
Ionis Pharmaceuticals USD 74M 8M 2026-03
Kangmei Pharma CNY 2.92B 228.09M 2026-03
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
MacroGenics USD 10.42M 2.95M 2026-03
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.48M 174K 2025-12
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Organigram Holdings CAD 53.39M 3.45M 2026-03
Ovoca Bio EUR 39K 408K 2025-06
Pfizer USD 16.17B 332M 2026-03
Pharma Mar EUR 51.19M 9.4M 2026-03
Qiagen NV USD 402.61M 9.05M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 482M 85M 2026-03
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
Sartorius EUR 366.6M 74.9M 2026-03
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Takeda JPY 876.35B 118.43B 2026-03
Tilray USD 109.07M 2M 2025-09
Zealand Pharma A/S 340M 94.1M 2025-12
Zz Pientze Pharmaceu CNY 1.06B 60.42M 2026-03